The National Ovarian Cancer Audit (NOCA), part of the National Cancer Audit Collaborating Centre (NATCAN), has published a report on care received by women diagnosed with ovarian cancer between 1 January and 31 December 2022 in England, and 1 January 2022 and 31 December 2023 in Wales. It found that approximately seven out of ten women in England, and three out of four in Wales, survived at least one year after diagnosis. While approximately four out of seven patients in England, and two out of three in Wales, survived at least two years after diagnosis.
Approximately seven out of ten women in England, and three out of four in Wales, survived at least one year after diagnosis
For both England and Wales, report findings included:
Four out of ten women had an emergency admission in the 28 days prior to their ovarian cancer diagnosis
One out of four women newly diagnosed with stage 2 to 4 or unstaged ovarian cancer did not have any treatment recorded within nine months of diagnosis.
This report also contains five clinical recommendations relating to:
The current rate of emergency admissions
Non-treatment within 28 days following an emergency admission
Variation in treatment of women with stage 2 to 4, or unstaged ovarian cancer
Utilisation of platinum-based chemotherapy in women with epithelial ovarian cancer
Variation in one-year survival in women diagnosed with ovarian cancer.
Read the full report: You can view the report by clicking the button below.
Stay up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.
More cancer reports: This month, HQIP has published 7 reports on cancer care – to see all others, go to our reports page.
More information: For further information and related reports, go to the programme page on this website.
